Thoracic Chemotherapy May Advance Mesothelioma Treatment
Thoracic surgeon Dr. Marcello Migliore is convinced that adding hyperthermic intrathoracic chemotherapy to aggressive surgery can extend survival significantly for patients with pleural mesothelioma cancer. He wants others to know that, too. This seldom-used, controversial procedure, also known as HITHOC, involves circulating a heated, high-concentration chemotherapy solution throughout the chest cavity for 60 minutes immediately following aggressive mesothelioma surgery. The idea is to kill any microscopic tumor cells that evaded the surgeon, hopefully slowing a potential cancer recurrence. Unlike HIPEC, a similar procedu...
Source: Asbestos and Mesothelioma News - January 19, 2021 Category: Environmental Health Authors: Fran Mannino Source Type: news

Routine thoracic surgery safe during COVID-19 pandemic
(International Association for the Study of Lung Cancer) A study in theJournal of Thoracic Oncology (JTO) comparing surgeries performed at one Chinese hospital in 2019 with a similar date range during the COVID-19 pandemic found that routine thoracic surgery and invasive examinations were performed safely. TheJTO is the official journal of the International Association for the Study of Lung Cancer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - January 19, 2021 Category: Cancer & Oncology Source Type: news

Boosting your quercetin intake found to have heart-protective effects
(Natural News) Heart disease is a serious condition that can greatly reduce your quality of life. It can lead to cardiovascular events like stroke and heart attack that not only cause irreparable damage to survivors but also burden them with sky-high costs for emergency treatments like heart surgery. Fortunately, quercetin offers people with heart disease a more affordable alternative. Found in several... (Source: NaturalNews.com)
Source: NaturalNews.com - January 18, 2021 Category: Consumer Health News Source Type: news

When Is Bilateral ITA CABG Better Than a Single-ITA Approach? When Is Bilateral ITA CABG Better Than a Single-ITA Approach?
CABG using both right and left internal thoracic arteries may yield better outcomes than a single ITA approach in all but the youngest and oldest patients, hints a post hoc analysis of a major trial.Medscape Medical News (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - January 7, 2021 Category: Surgery Tags: Cardiology News Source Type: news

Preoperative Cardiac Biomarker Screening Underused in Noncardiac Surgery Preoperative Cardiac Biomarker Screening Underused in Noncardiac Surgery
Patients undergoing noncardiac surgery are at high risk for later mortality and cardiovascular events. Biomarker screening can flag those at risk but is infrequently used.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - December 18, 2020 Category: Cardiology Tags: Cardiology News Source Type: news

Research shows impact of bariatric surgery on cardiovascular disease risk in obese teens
(Children's Hospital Colorado) Researchers at Children's Hospital Colorado determined that the long-term risk of cardiovascular events including heart attack, congestive heart failure, stroke and coronary death was reduced by almost threefold for teenagers with type 2 diabetes who underwent bariatric surgery compared to those whose diabetes was only managed medically. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - December 10, 2020 Category: International Medicine & Public Health Source Type: news

Relationship between risk markers for cardiovascular disease and peri-implant diseases
ConclusionHigh levels of triglyceride and uric acid may pose a risk for both peri-implant diseases and cardiovascular diseases. Prior to dental implant surgery, patients ’ serum biochemical parameters should be checked. (Source: Dental Technology Blog)
Source: Dental Technology Blog - December 9, 2020 Category: Dentistry Source Type: news

What Areas of the Physical Examination are Important in the Pre-participation Physical Examination?
Discussion Participation in organized or non-organized, recreational to elite sports activities can provide excellent recreational and leisure time activities and improve physical and mental health for participants. The Aspen Institute in 2018 reported that more kids are being physically active, more are trying different sports, and multisports play is increasing rather than strict specialization. Unfortunately they note that there is an economic inequality with children from lower-socioeconomic circumstances playing less organized sports. About 70% of children and youth participate in an individual or team sport, but unfo...
Source: PediatricEducation.org - December 7, 2020 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news

New Data Demonstrate Long-Term Benefit of IMBRUVICA ® (ibrutinib) as First-Line Treatment for High-Risk Chronic Lymphocytic Leukemia
This study highlighted the need for cytogenetic/molecular testing before CIT treatment, consistent with clinical treatment guidelines.[8],[9]Real-World Prognostic Biomarker Testing, Treatment Patterns, And Dosing Among Patients With CLL/SLL From the informCLL™ Prospective Observational Registry (Abstract #547)An oral presentation on Monday, December 7, will feature results from the informCLL™ real-world prospective observational registry assessing treatment patterns in the era of novel agents.4 Key Study Findings:· The most common index treatment was IMBRUVICA®; the majority of patients treated with ...
Source: Johnson and Johnson - December 6, 2020 Category: Pharmaceuticals Tags: Innovation Source Type: news

Disease-Free Survival Data from CAPTIVATE Study Demonstrate Benefit of IMBRUVICA ® (ibrutinib)-Based Regimen as Fixed Duration, First-Line Treatment for Patients with Chronic Lymphocytic Leukemia
December 5, 2020 (RARITAN, N.J.) – New data from the Phase 2 CAPTIVATE study were presented today during an oral session at the 2020 American Society of Hematology (ASH) Annual Meeting (Abstract #123). The study evaluated the efficacy and safety of IMBRUVICA® (ibrutinib) plus venetoclax in the treatment of adult patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) and showed that, after achieving undetectable minimal residual disease (uMRD) in both the blood and bone marrow with the IMBRUVICA® combination regimen, the one-year disease-free survival (DFS) of patients randomized ...
Source: Johnson and Johnson - December 5, 2020 Category: Pharmaceuticals Tags: Innovation Source Type: news

American Heart Association, Nov. 13-17
The annual meeting of the American Heart Association was held virtually this year from Nov. 13 to 17 and attracted participants from around the world, including cardiovascular specialists, surgeons, and nurses as well as other health care... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - December 1, 2020 Category: Pharmaceuticals Source Type: news

Those who can should pay for the vaccine: Naresh Trehan, MD Medanta Hospital
Dr Naresh Trehan, cardiovascular surgeon and chairman and MD of Medanta, tells ET in an interview over the phone that the government should rope in private players in vaccinating people. (Source: The Economic Times)
Source: The Economic Times - November 28, 2020 Category: Consumer Health News Source Type: news

Weight-loss surgery weakens teenagers' bones
MRI and CT exams illuminate the negative effect a common weight loss surgery...Read more on AuntMinnie.comRelated Reading: CT lung screening scans also work for bone density Cardiac CT shows promise for osteoporosis screening AAOS: QCT finds low bone density in lumbar fusion patients 3D DEXA enhances hip fracture risk prediction Bone density scans help identify cardiovascular disease (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - November 24, 2020 Category: Radiology Source Type: news

New XARELTO ® (rivaroxaban) Peripheral Artery Disease (PAD) Data from EXPLORER Clinical Research Program to be Unveiled at American Heart Association (AHA) Scientific Sessions 2020
RARITAN, N.J., November 9, 2020 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that 10 data presentations will be shared at the virtual American Heart Association (AHA) Scientific Sessions 2020 from November 13-17. Most notably, four new sub-analyses of XARELTO® (rivaroxaban) from the landmark VOYAGER PAD trial, part of the EXPLORER global cardiovascular research program, will be presented, including two live, featured science oral presentations. “We're pleased VOYAGER PAD was selected to be front and center once again at a major medical congress, as there's an urgent need f...
Source: Johnson and Johnson - November 9, 2020 Category: Pharmaceuticals Tags: Innovation Source Type: news

Janssen Headlines American Society of Hematology Annual Meeting With More Than 35 Presentations Highlighting Deep, Diverse Oncology Pipeline and Portfolio
RARITAN, N.J., November 5, 2020 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today more than 35 company-sponsored studies, including 10 oral presentations, will be featured at the 62nd American Society of Hematology (ASH) Annual Meeting and Exposition taking place virtually December 5-8, 2020.In multiple myeloma, highlights include Phase 1b/2 results for the B-cell maturation antigen (BCMA)-targeted chimeric antigen receptor T-cell (CAR-T) therapy ciltacabtagene autoleucel (cilta-cel); new and updated data for the anti-CD38 monoclonal antibody DARZALEX® (daratumumab) and the subcutane...
Source: Johnson and Johnson - November 5, 2020 Category: Pharmaceuticals Tags: Innovation Source Type: news

Uniportal Video-Assisted Thoracic Surgery for Lung Cancer Uniportal Video-Assisted Thoracic Surgery for Lung Cancer
Should this procedure have a role in the treatment of lung cancer? A new consensus statement provides guidance and recommendations.Translational Lung Cancer Research (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - November 5, 2020 Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news

Metabolic Surgery Linked to Reduced Risk for MACE After MI
MONDAY, Oct. 26, 2020 -- Metabolic surgery is associated with a reduced risk for major adverse cardiovascular events and death among patients with previous myocardial infarction (MI) and obesity, according to a study published online Oct. 26 in... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - October 26, 2020 Category: Pharmaceuticals Source Type: news

Janssen Submits Application to U.S. FDA for New Indication to Expand Use of XARELTO ® (rivaroxaban) in Patients with Peripheral Artery Disease
RARITAN, NJ, October 26, 2020 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today it has submitted a supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration (FDA) for a new indication to expand the use of XARELTO® (rivaroxaban) in patients with peripheral artery disease (PAD). If approved, this new indication for the XARELTO® vascular dose (2.5 mg twice daily plus aspirin 75-100 mg once daily) would include reducing the risk of major thrombotic vascular events such as heart attack, stroke and amputation in patients after recent lower-extremity revasculariz...
Source: Johnson and Johnson - October 26, 2020 Category: Pharmaceuticals Tags: Innovation Source Type: news

Temple treats 1st patient in trial of RejuvenAir Metered Cryospray System for COPD with CB
(Temple University Health System) Temple University Hospital has treated the first patient in a multicenter international clinical trial utilizing the RejuvenAir ® System for the treatment of patients suffering from moderate to severe COPD with chronic bronchitis. Chronic bronchitis is characterized by a productive cough for months or years. Dr. Gerard Criner, Chair and Professor of Thoracic Medicine and Surgery at the Lewis Katz School of Medicine and Director of the Temple Lung Center, is the overall principal investigator. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - October 20, 2020 Category: International Medicine & Public Health Source Type: news

Howerton Joins Washington Regional Clinic (Movers & Shakers)
Tara Howerton has been hired as an advanced practice registered nurse at Washington Regional Cardiovascular & Thoracic Surgery Clinic in Fayetteville. (Source: Arkansas Business - Health Care)
Source: Arkansas Business - Health Care - October 19, 2020 Category: American Health Source Type: news

MACE Up for High-Risk Patients After Noncardiac Surgery
FRIDAY, Oct. 16, 2020 -- About 20 percent of high-risk patients undergoing noncardiac surgery will develop one or more major adverse cardiovascular events (MACE) within one year, according to a study published online Oct. 15 in the European Heart... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - October 16, 2020 Category: Pharmaceuticals Source Type: news

Having Heart Disease Can Make Other Surgeries More Risky
THURSDAY, Oct. 15, 2020 -- Heart patients may face a greater chance of cardiovascular complications after having major surgery that doesn't involve the heart, new research suggests. Twenty percent of these patients experienced heart troubles within... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - October 15, 2020 Category: General Medicine Source Type: news

HCA Houston Healthcare plans $60M expansion project at Museum District hospital
HCA Houston Healthcare, the local division of Nashville-based HCA Healthcare Inc. (NYSE: HCA), plans to enhance and expand its hospital near the Texas Medical Center. The project will cost $60 million, an HCA spokesperson confirmed. Located at 1313 Hermann Drive in the Museum District, HCA Houston Healthcare Medical Center is just northeast of the TMC. Updates will include adding a cardiovascular operating room; enhancing robotic operating rooms, operating su ites and pre- and post-surgery areas;… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - October 14, 2020 Category: Pharmaceuticals Authors: Chris Mathews Source Type: news

Latest T-Cell Clinical Trial Opens for Mesothelioma Patients
Memorial Sloan Kettering Cancer Center in New York City has begun recruiting patients with pleural mesothelioma for its latest — and potentially most promising — clinical trial involving T-cell therapy. The novel study stems from the U.S. Food and Drug Administration’s recent Investigational Drug Application approval of ATA2271, a chimeric antigen receptor known as CAR T-cell therapy. This latest therapy will be tested in a phase I, dose-escalation clinical trial. It will involve the removal and genetic modification of a patient’s T cells, a type of white blood cell, that will be separated in the la...
Source: Asbestos and Mesothelioma News - October 8, 2020 Category: Environmental Health Authors: Fran Mannino Source Type: news

FDA Approves Opdivo, Yervoy Combination for Mesothelioma
The U.S. Food and Drug Administration has approved the immunotherapy combination of Opdivo and Yervoy for first-line treatment of unresectable malignant pleural mesothelioma. It was the first new drug regimen approved for mesothelioma in 16 years and only the second systemic therapy ever. The historic treatment approval for this cancer without a cure was the first since the FDA approved the chemotherapy combination of pemetrexed and cisplatin in 2004. “This marks the beginning of a new era for mesothelioma,” Dr. Bernardo Goulart, medical oncologist at Seattle Cancer Care Alliance, told The Mesothelioma Center a...
Source: Asbestos and Mesothelioma News - October 5, 2020 Category: Environmental Health Authors: Fran Mannino Source Type: news

FDA Approves Opdivo, Yervoy Combination for Mesothelioma
The U.S. Food and Drug Administration has approved the immunotherapy combination of Opdivo and Yervoy for first-line treatment of unresectable malignant pleural mesothelioma. It was the first new drug regimen approved for mesothelioma in 16 years and only the second systemic therapy ever. The historic treatment approval for this cancer without a cure was the first since the FDA approved the chemotherapy combination of pemetrexed and cisplatin in 2004. “This marks the beginning of a new era for mesothelioma,” Dr. Bernardo Goulart, medical oncologist at Seattle Cancer Care Alliance, told The Mesothelioma Center a...
Source: Asbestos and Mesothelioma News - October 5, 2020 Category: Environmental Health Authors: Fran Mannino Source Type: news

Janssen Submits New Drug Application (NDA) to U.S. FDA for UPTRAVI ® (selexipag) Injection for Intravenous Use to Treat Pulmonary Arterial Hypertension (PAH)
SOUTH SAN FRANCISCO, CA – September 30, 2020 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced the submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for UPTRAVI® (selexipag) as an injection for intravenous (IV) use for the treatment of pulmonary arterial hypertension (PAH, WHO Group I) in adults with WHO functional class (FC) II–III, who are currently prescribed oral UPTRAVI but are temporarily unable to take oral therapy. In patients with PAH, interruptions in treatment should be avoided due to the progressive nature of the disease...
Source: Johnson and Johnson - September 30, 2020 Category: Pharmaceuticals Tags: Innovation Source Type: news

Featured Review: Thoracic imaging tests for the diagnosis of COVID-19
How accurate is chest imaging for diagnosing COVID-19?Why is this question important?People with suspected COVID-19 need to know quickly whether they are infected, so that they can self-isolate, receive treatment, and inform close contacts. Currently, formal diagnosis of COVID-19 infection requires laboratory analysis of blood or nose and throat samples. The laboratory test, called RT-PCR, requires specialist equipment and takes at least 24 hours to produce a result. Further, RT-PCR is not completely accurate and a second RT-PCR or a different test may be required to confirm the diagnosis.COVID-19 is a respiratory infectio...
Source: Cochrane News and Events - September 29, 2020 Category: Information Technology Authors: Rachel Klabunde Source Type: news

Metabolic Surgery May Cut Risk for Cardiovascular Events, Death
MONDAY, Sept. 28, 2020 -- Metabolic surgery on patients with morbid obesity and pharmacologically treated hypertension is associated with lower risk for major adverse cardiovascular events (MACE) and all-cause mortality versus individuals with... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - September 28, 2020 Category: Pharmaceuticals Source Type: news

Study identifies weight-loss threshold for heart health in patients with obesity, diabetes
(Cleveland Clinic) A Cleveland Clinic study shows that 5 to 10 percent of surgically induced weight loss is associated with improved life expectancy and cardiovascular health. In comparison, about 20 percent weight loss is necessary to observe similar benefits with a non-surgical treatment. The findings also show that metabolic surgery may contribute health benefits that are independent of weight loss. The study is published in the October issue of Annals of Surgery. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - September 23, 2020 Category: International Medicine & Public Health Source Type: news

Management and in-hospital mortality of 2235 patients with a traumatic intimal tear of the thoracic aorta - Jacob-Brassard J, Al-Omran M, Nathens AB, Forbes TL, De Mestral C.
OBJECTIVE: Our goal was to describe contemporary management and in-hospital mortality associated with blunt thoracic aortic intimal tears (IT) within the American College of Surgeons Trauma Quality Improvement Program. SUMMARY BACKGROUND DATA: The evid... (Source: SafetyLit)
Source: SafetyLit - September 7, 2020 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news

Heart rhythm disorders are best managed when patients are listened to
(European Society of Cardiology) Atrial fibrillation is the most common heart rhythm disorder and increases the risk of stroke by fivefold. Patients with irregular heartbeats should choose the treatment plan with their health professionals, according to European Society of Cardiology (ESC) Guidelines published online today in European Heart Journal, and on the ESC website. The document was developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS). (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - August 29, 2020 Category: International Medicine & Public Health Source Type: news

Cardiology compensation continues to rise; new interventional measures reported
(American College of Cardiology) MedAxiom, an American College of Cardiology Company and the premier source for cardiovascular organizational performance solutions, has released its eighth annual Cardiovascular Provider Compensation and Production Survey. The report reveals trends across cardiology, surgery, advanced practice providers (APPs) and non-clinical compensation that help cardiovascular organizations as they face a new normal and are reevaluating compensation models and the definition of work productivity. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - August 27, 2020 Category: International Medicine & Public Health Source Type: news

Hitting the nail on the head: overcoming therapeutic resistance in lung cancer
(Medical University of South Carolina) An interdisciplinary team at the Medical University of South Carolina has shown that Neuropilin 2, a protein highly expressed in lung cancer cells, is a critical player in conferring resistance to targeted therapy in lung cancer. Their findings are reported in an article published in The Journal of Thoracic and Cardiovascular Surgery. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - August 24, 2020 Category: Cancer & Oncology Source Type: news

What Are the Main Acyanotic Congenital Heart Diseases?
Discussion Congenital heart diseases (CHD) are malformations of the heart and great vessels. It occurs in about 5-8/1000 live births. Cyanotic congenital heart disease is often noted perinatally because of cyanosis, respiratory distress and/or poor feeding or other distress type problems. A review can be found here. Acyanotic congenital heart disease (ACHD) can present at birth but often is seen in older children or adults unless the lesions are severe, especially obstructive lesions. Severe lesions may also cause cyanosis and distress type problems in patients also. Shunting lesions cause problems by diverting blood flo...
Source: PediatricEducation.org - August 17, 2020 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news

Mesothelioma Clinical Trials Resume After COVID-19 Disruption
When the COVID-19 pandemic struck earlier this year, clinical trials at medical centers around the world slowed enrollment or placed trial activities on hold. As businesses begin to reopen in the United States, more treatment centers are resuming mesothelioma study activities and ramping up enrollment. Clinical research trials offer patients access to experimental mesothelioma treatments that haven’t yet been approved by the U.S. Food and Drug Administration. These treatments may provide higher chances of survival than the current standard of care. “So far, every patient I have seen during the COVID-19 pande...
Source: Asbestos and Mesothelioma News - August 10, 2020 Category: Environmental Health Authors: Fran Mannino Source Type: news

Study Shows Peritoneal Mesothelioma Surgery Underutilized
The continued underutilization of aggressive surgery for peritoneal mesothelioma is shortening survival time dramatically for patients who could qualify for, and benefit from, the highly effective procedure. Only a third of those diagnosed with peritoneal mesothelioma are undergoing potentially curative cytoreductive mesothelioma surgery, according to a comprehensive study of the National Cancer Database by researchers at Inova Fairfax Medical Center in Virginia. Annals of Surgical Oncology published the mesothelioma study earlier this year. “Patients who have the surgery perform much better than those who do not. Ye...
Source: Asbestos and Mesothelioma News - July 28, 2020 Category: Environmental Health Authors: Fran Mannino Source Type: news

Quitline plus surgery are big motivators for giving up smoking
(University of California - Davis Health) Smokers who have thoracic surgery are much more likely to stop using tobacco if they also complete a quitline intervention, a new UC Davis Health study shows. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 28, 2020 Category: International Medicine & Public Health Source Type: news

Thorough Risk Assessment Essential Prior to Noncardiac Surgery
MONDAY, July 27, 2020 -- Comprehensive preoperative assessment of cardiovascular risk with history and physical examination is essential prior to noncardiac surgery, according to a review published in the July 21 issue of the Journal of the American... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 27, 2020 Category: Pharmaceuticals Source Type: news

Phase III data show Roche ’s Port Delivery System with ranibizumab enabled over 98% of patients to go six months between treatments for neovascular age-related macular degeneration
Basel, 22 July 2020 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced detailed results from the phase III Archway study evaluating its investigational Port Delivery System with ranibizumab (PDS) for the treatment of neovascular or “wet” age-related macular degeneration (nAMD), a leading cause of blindness globally.1 In Archway, 98.4% of PDS patients were able to go six months without needing additional treatment and achieved vision outcomes equivalent to patients receiving monthly ranibizumab eye injections, a current standard of care. In the study, PDS was generally well-tolerated, with a favourable benefit...
Source: Roche Media News - July 22, 2020 Category: Pharmaceuticals Source Type: news

Phase III data show Roche ’s Port Delivery System with ranibizumab enabled over 98% of patients to go six months between treatments for neovascular age-related macular degeneration
Basel, 22 July 2020 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced detailed results from the phase III Archway study evaluating its investigational Port Delivery System with ranibizumab (PDS) for the treatment of neovascular or “wet” age-related macular degeneration (nAMD), a leading cause of blindness globally.1 In Archway, 98.4% of PDS patients were able to go six months without needing additional treatment and achieved vision outcomes equivalent to patients receiving monthly ranibizumab eye injections, a current standard of care. In the study, PDS was generally well-tolerated, with a favourable benefit...
Source: Roche Investor Update - July 22, 2020 Category: Pharmaceuticals Source Type: news

Commercially Viable Mobile Lung Screening Program Feasible
TUESDAY, July 14, 2020 -- Developing a commercially viable and financially sound mobile program for lung screening is feasible, according to a study published online July 14 in the Annals of Thoracic Surgery. James R. Headrick Jr., M.D., from the... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 14, 2020 Category: Pharmaceuticals Source Type: news

Lung screening bus brings high-tech health care directly to patients
(The Society of Thoracic Surgeons) A mobile platform for lung cancer screening with low-dose computed tomography (CT) can be developed with limited financial risk and take powerful screening tests directly to patients, including underserved rural areas where rates of new lung cancer cases tend to be higher. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - July 14, 2020 Category: Cancer & Oncology Source Type: news

Latissimus Dorsi Flap for Thoracic Wall Defects Latissimus Dorsi Flap for Thoracic Wall Defects
Is this technique a safe and effective reconstructive option for post-sternotomy thoracic wall defects?ePlasty, Open Access Journal of Plastic Surgery (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 8, 2020 Category: Consumer Health News Tags: Plastic Surgery & Aesthetic Medicine Journal Article Source Type: news

Association of trauma center level and patient volume with outcomes for penetrating thoracic trauma - Checchi KD, Calvo RY, Badiee J, Rooney AS, Sise CB, Sise MJ, Bansal V, Martin MJ.
BACKGROUND: We investigated the potential link between trauma center American College of Surgeons verification level and institutional volume of penetrating thoracic trauma with outcomes for patients with penetrating thoracic trauma. METHODS: Penetrating... (Source: SafetyLit)
Source: SafetyLit - July 6, 2020 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news

Cryoablation Study for Mesothelioma Opening at UCLA
Researchers at UCLA Jonsson Comprehensive Cancer Center will soon begin studying the pre-surgery use of cryoablation as a potential early adjuvant therapy for patients with pleural mesothelioma. The pilot study will measure immune system stimulation through local tumor infiltration in hopes of extending patient survival in the future. Cryoablation, also known as cryotherapy or cryosurgery, freezes localized tumors with liquid nitrogen or argon gas. It has been proven effective in killing tumor cells with extreme cold. It is currently used on kidney, liver and prostate cancers, but its use in priming a person’s own i...
Source: Asbestos and Mesothelioma News - July 1, 2020 Category: Environmental Health Authors: Fran Mannino Source Type: news

What Causes Bradycardia?
Discussion Bradycardia is a heart rate below what the lowest value that is normal for age. Infants and children have higher heart rates that slowly decrease with age to adult levels. It is usually noted as an incidental finding because of increased vagal tone. Reasons for cardiology referral include associated heart murmur, syncope especially if associated with exercise or unusual triggers, other signs such as chest pain or palpitations, family history of sudden cardiac death, congenital heart disease or familial heart disease, bradycardic medication use, or unusual symptoms associated with the concern. Severe bradycardia ...
Source: PediatricEducation.org - June 22, 2020 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news

What Causes Free Peritoneal Fluid?
Discussion Peritoneal fluid is normal. It decreases the friction of the peritoneum covering abdominal and pelvic organs and helps to protect them and allow their movement. A normal amount of peritoneal fluid is expected on radiological evaluation. Increased peritoneal fluid is a continuum and is concerning as a wide variety of pathological causes are associated with it such as abdominal trauma and appendicitis. At the far end of the scale is ascites that is the accumulation of free fluid more than 25 ml. It is usually associated with abdominal distension but fluid must accumulate before distension can occur and therefore i...
Source: PediatricEducation.org - June 8, 2020 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news

Healthy People Shouldn ’ t Take Daily Aspirin To Prevent Heart Disease, Review Finds
(CNN) — Still taking a daily aspirin to ward off heart attacks? You might want to think again, according to a new review. Aspirin is still one of the most commonly used medications in the world, even though it’s no longer recommended as a preventative by many health authorities. There is no evidence that low-dose aspirin — less than 325 milligrams a day — should be taken by most adults in good cardiovascular health, according to a new review of existing research that published Wednesday in the British Journal of Clinical Pharmacology. The review, which focused on the risks and benefits of low-dose d...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - June 3, 2020 Category: Consumer Health News Authors: Health – CBS Boston Tags: Health News aspirin CNN Source Type: news